Correlation Between Pfizer and Corner Growth

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Corner Growth at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Corner Growth into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Corner Growth Acquisition, you can compare the effects of market volatilities on Pfizer and Corner Growth and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Corner Growth. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Corner Growth.

Diversification Opportunities for Pfizer and Corner Growth

0.64
  Correlation Coefficient

Poor diversification

The 3 months correlation between Pfizer and Corner is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Corner Growth Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corner Growth Acquisition and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Corner Growth. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corner Growth Acquisition has no effect on the direction of Pfizer i.e., Pfizer and Corner Growth go up and down completely randomly.

Pair Corralation between Pfizer and Corner Growth

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Corner Growth. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 90.47 times less risky than Corner Growth. The stock trades about 0.0 of its potential returns per unit of risk. The Corner Growth Acquisition is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  2.99  in Corner Growth Acquisition on September 3, 2024 and sell it today you would lose (2.99) from holding Corner Growth Acquisition or give up 100.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy44.94%
ValuesDaily Returns

Pfizer Inc  vs.  Corner Growth Acquisition

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Corner Growth Acquisition 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Corner Growth Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Corner Growth is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pfizer and Corner Growth Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Corner Growth

The main advantage of trading using opposite Pfizer and Corner Growth positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Corner Growth can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corner Growth will offset losses from the drop in Corner Growth's long position.
The idea behind Pfizer Inc and Corner Growth Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges